Pfizer's COVID-19 vaccine has become available in Korea for people over 12 years of age.

The MFDS announced on the 16th that it has approved the change of Comirnaty, which can be used to prevent COVID-19 among people aged 12 and older.
The dosage and indications of the vaccine can be diluted once with 0.3ml and inoculated additionally after three weeks, just like the existing 16 years old or older. Pfizer vaccines have also been approved in the United States (May 10, Europe (June 2), Canada (May 5) and Japan (May 31).

The MFDS determined that the overall safety was similar to that of those aged 16 or older and was in good condition.

In the age of 12–15 years